Amdocs LimitedFull report →1 / 15
DOXNASDAQThe short version

Amdocs Limited

Amdocs sells the billing and customer-management software that runs the world's largest phone carriers; after a 47% share-price fall its cash engine looks intact, yet at $6.18B it sits below this framework's size line.

A quarter-century climb from under $20 to a $98.85 high in 2023, then a slide that cut the shares nearly in half — from $94 in June 2025 to a $49.87 low a year later.
Mkt cap $6.8BNet debt $682.7MEV $7.5BP/E FY27E 6.9×ND/EBITDA FY27E 0.6×
$55.28
Share price
$6.18B
Market cap
7.25%
Adj. FCF yield
−47%
Peak-to-trough drawdown
SwipeScroll▾
Snapshot

Amdocs Limited in numbers

Price
$55.28as of 2026-07-30
Mkt cap
$6.8B
Net debt
$682.7M
EV
$7.5B
12m perf
−35.8%
3m ADV
$79.3M
Year to Sep (USD)2023202420252026E2027E2028E
Sales4.9B5.0B4.5B4.7B4.8B5.1B
EBITDA922.8M954.9M1.0B1.2B1.2B1.3B
EBIT724.9M759.7M812.2M966.3M1.0B1.0B
EBIT margin14.8%15.2%17.9%20.6%21.1%20.0%
EPS4.494.255.057.418.068.94
EV/EBITDA8.1×7.9×7.5×6.3×6.2×5.8×
EV/EBIT10.4×9.9×9.3×7.8×7.4×7.3×
P/E12.3×13.0×10.9×7.5×6.9×6.2×
FCF yield10.2%9.1%9.4%9.5%10.8%12.8%
Gearing3.6%8.7%9.4%–––
Consensus: S&P Capital IQ (CapIQ) · as of 2026-07-31Derived from run data; ratios use the latest price.
IThe business
Business

A single-segment software backbone for the world's phone carriers

FY2025 revenue by region
North America is ~66% of the top line.
  • One business, one segment. Amdocs sells the billing, ordering and customer-management software plus the managed-services teams that run large phone carriers' back offices. FY2025 revenue was $4.53B.
  • Recurring by design. About 66% of revenue is managed services that renew close to 100%, and booked-but-unbilled backlog stood near $6.4B — visibility years out.
  • Asset-light. Capex roughly halved to about $104M in FY2025; the model throws off cash rather than consuming it.
Customers

Two carriers pay nearly half the bills

Customer concentration, FY2025
Customer% of revenue
AT&T25.9%
T-Mobile19.9%
All other customers54.2%
  • Concentrated demand. AT&T was 25.9% of FY2025 revenue and T-Mobile 19.9% — together nearly half the top line comes from two US carriers.
  • Sticky, but budget-driven. T-Mobile re-signed a multi-year deal in Q1 FY2026 yet is still guided to lower spend: renewals hold even as carrier budgets shrink.
  • Mature end market. Organic growth runs near 1.5%; roughly half of the ~3% headline growth is inorganic.
IIIThe story now
The fit

Outside the framework's universe (U2 not met); contested: P2

$6.18B
Market cap vs $10B line
7.25%
Adj. FCF yield vs 8.5% bar
0.69
Diagnosis: leans temporary
High
Confidence
  • The size gate. At $55.28 the 111.7M shares are worth about $6.18B — roughly $3.8B under the framework's $10B floor. A sub-$10B name is out before any pillar can qualify it; all four jurors agreed.
  • Drawn down, not structural. At the June-2025 peak of $94.08 the same share count implied about $10.5B, above the line — the miss is the ~47% drawdown, but the framework measures scale today.
  • What's contested. P2 (cash-flow consistency) split: one model family read it as met, the other as cannot-determine — a window-length disagreement, not a factual dispute, and not a gate.
Market cap uses the FY2025 period-end share count; a different current count shifts $6.18B modestly, not to the $10B line.
Dislocation

The 47% fall came on two guidance days, not one panic

−7.9%
Day after Q4 FY2025 print
−8.6%
Day after Q1 FY2026 print
−47%
Peak to trough, 378 days
3.1x
Peak volume vs median
  • Dated triggers. The Nov-11-2025 Q4 print set a soft FY2026 outlook and the stock fell ~7.9%; the Feb-3-2026 Q1 print fell ~8.6% even as revenue rose 4.1% and a T-Mobile renewal was signed.
  • Force in the tape. Volume ran 3.1x the trailing median through the fall, with single-day spikes near 6.9x and 5.3x — selling with emotion, not a quiet drift.
  • Counter-fact. The steepest leg, June 2026 to the $49.87 low, carried no dated company catalyst; news ties it only to sector-wide AI-disruption fear, so part reads as an orderly de-rating.
Diagnosis

Earnings rose while the share price nearly halved

Diluted EPS rose through the drawdown
  • Inverted signature. Through the drawdown FY2025 earnings rose — GAAP diluted EPS +18.8% and non-GAAP +8.5% — while the multiple compressed. Price fell; earning power didn't.
  • A deliberate break. The 9.4% reported revenue drop was a chosen phase-out of low-margin, non-core work; excluding it, revenue grew 3.1%. That anniversaries rather than compounds.
  • Counter-fact. An adversarial trial put the impairment at 0.69 leans-temporary, but a DCF-lite at r=10% puts the market-implied FCF (~$618M) inside the permanent band — the gap exists only if temporary.
Durability

The ten-year durability test comes up just short

0.61
P1 year-10 conviction (gate: not met)
~66%
Revenue from recurring services
$940M
Consensus FY2029 FCFfrom $652M in FY2026
  • Genuine durability. About 66% recurring revenue renewing near 100%, ~$6.4B backlog, an asset-light model, and consensus FCF modeled rising from $652M (FY2026) to $940M (FY2029).
  • But not 'very high conviction.' Organic growth is ~1.5%, the core carrier market is mature, SaaS challengers attack the bespoke model, and ~46% of revenue sits in two carriers — the year-10 gate resolves not met.
  • Counter-fact. A lower year-10 FCF is hard to picture: free cash flow held $530–698M through the disruption, and the ~3.3%/yr buyback keeps compounding per-share value even at ~3% growth.
Moat

A mature market and real challengers, but not a secular melt

Structural-decline read
SignalReading
End marketMature carrier IT, ~1.5% organic growth
Named as a rivalCSG Systems' FY2025 filing lists Amdocs directly
Valuation~1.4x FY2025 sales after the fall
Structural test (X3)Not a hit — read as cyclical, not secular
  • Real pressure. The carrier-IT market is mature and SaaS challengers target the bespoke-integration model; a rival's FY2025 filing names Amdocs directly as a competitor.
  • Not a melt. The structural-decline test came back not a hit — the jury read the softness as cyclical and self-inflicted (the phase-out), not a secular loss of share or pricing.
  • Not consensus-hyped either. At about 1.4x FY2025 sales after a 47% fall with ~3% growth expected, this is the opposite of an extreme-multiple, saturated-growth story.
Self-help

A relentless buyback has retired a tenth of the shares

Diluted share count
  • Executed, not promised. Buybacks were roughly $490–563M of actual cash a year — $2.11B across FY2022–FY2025 — shrinking diluted shares 9.6%, about 3.3% annually.
  • Full payout. Repurchases plus dividends returned more than 100% of free cash flow into Q2 FY2026; the share-count-rising hard-fail test is negative.
  • Counter-fact. Recent vintages were bought near $85–90 against a ~$55 quote, and continued capacity increasingly leans on a commercial-paper program launched March 2026, not current FCF.
Balance sheet

The balance sheet can outlast; the headroom is thinning

Cash and short-term investments
  • Room to outlast. The only funded debt is a $650M senior note at 2.538% due June 2030; the $800M revolver runs to July 2029, undrawn and covenant-compliant, with investment-grade ratings intact.
  • Headroom is thinning. Returning more than all its FCF drew cash and short-term investments from $514M (FY2024) to $325M (FY2025) to about $214M by March 2026.
  • Class is drifting. Net debt was 0.35x EBITDA at FY2025 (fortress); by Q2 FY2026 it had risen toward ~0.7x (moderate), lifting the yield bar the company must clear.
IVThe price
Yield vs bar

Adjusted cash yield sits just below the fortress bar

Adjusted FCF yield vs the fortress bar
  • Just under the bar. Hand-built adjusted FCF yield is 7.25% now and 7.48% on a three-year average, against the 8.5% fortress bar — short by roughly 100–125 basis points.
  • The haircut does it. On the raw, unadjusted definition the yield is 10.4% and clears comfortably; it is the ~$197M stock-comp-plus-acquisition adjustment that pulls it under the line.
  • Counter-fact. If the balance sheet keeps drifting to moderate, the bar rises to 10% and the gap widens.
Adjusted FCF = free cash flow minus stock-based comp minus a trailing five-year average of acquisition spend.
Forward path

Consensus has the yield clearing the bar by FY2027

Adjusted forward FCF yield
Crosses the 8.5% fortress bar in FY2027 on a static price.
  • Consensus crosses in FY2027. Applying the same haircut to consensus FCF, adjusted forward yield runs 7.35% (FY2026), 8.74% (FY2027) and 10.94% (FY2028) — clearing the 8.5% bar with no re-rating.
  • Mechanical on a flat price. The crossing rests on consensus FCF rising to $737M in FY2027 off a year revenue fell 9.4%; any upward re-rating would compress the yield back below the bar.
  • Dividend adds to it. The payout yields ~3.8% (rising to ~4.1% on the proposed FY2026 step-up), took ~35% of FY2025 FCF, and carries roughly 3x forward cover.
The 3x test

A 3x from here would need about $18.5B

DCF-lite value vs the 3x target
  • The target. A 3x in three years from $6.18B implies about $18.5B of value — the framework's yardstick, stated as arithmetic.
  • The models don't reach it. A DCF-lite at r=10% caps the temporary case near $6.5–8.1B and the permanent case at $5.3–5.8B, below today's market value.
  • What it would take. FCF compounding far faster than the temporary case assumes, and consensus conceding a full re-acceleration of the ~1.5% organic line.
What to watch

A cash-rich, buyback-heavy backbone in a real dislocation — but too small for this framework and short of its bars.

This is the short version of a fixed framework test, built criterion by criterion across the report's evidence tabs.

Compiled from the full report · 2026-07-31 · For information, not investment advice.